• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Raptor Pharmaceuticals Corp. (RPTP)

    -NasdaqGM
    9.63 Up 0.29(3.10%) Dec 26, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 23,764   16,313   12,134   10,248  
    Cost of Revenue3,917  995  1,314  786  
    Gross Profit 19,847   15,318   10,820   9,462  
    Operating Expenses
    Research Development9,001  11,077  9,547  7,759  
    Selling General and Administrative15,078  13,326  12,064  12,372  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (4,232) (9,085) (10,791) (10,669)
    Income from Continuing Operations
    Total Other Income/Expenses Net2,571  (105)(1,115)1,321  
    Earnings Before Interest And Taxes(1,661)(9,190)(11,906)(9,348)
    Interest Expense4,380  3,497  2,979  2,744  
    Income Before Tax(6,041)(12,687)(14,885)(12,092)
    Income Tax Expense(8)6  6   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(6,033)(12,693)(14,891)(12,092)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (6,033) (12,693) (14,891) (12,092)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (6,033) (12,693) (14,891) (12,092)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.